In addition to their virucidal capacity, several studies have shown that EGCG can act by blocking the necessary receptors for viral attachment to the target cell, as in the case of HIV, where the drug binds to CD4 expressed on T cells and inhibits the virus binding to this site, blocking viral infection [20,52]. This evidence concerns the gene CD4 and viral infectious disease.